UNICANCER
2 clinical trials · 2 recruiting · OTHER
Trials by UNICANCER
RECRUITINGPhase 3NCT07237256
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
The advent of CDK4/6 inhibitors (drugs designed to block the action of CDK4/6 proteins, which play a key role in cell proliferation) has improved treatment prospects for patients...
Sponsor: UNICANCEREnrolling: 390220 locations
Breast Cancer
RECRUITINGPhase 3NCT06496581
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
PEACE-6 Poor Responders is an international, multicenter, open-label, controlled, randomized, phase III trial to evaluate the efficacy and safety of 177Lu-PSMA-617 when...
Sponsor: UNICANCEREnrolling: 50020 locations
Prostate Cancer Metastatic